Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

2.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

810
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulated Cell Death in Myocardial Infarction.

Circulation research·2025
Same author

Reformulation of the Necroptosis Pathway in Reperfused Myocardial Infarction.

Circulation·2025
Same author

Assessing C3 glomerulopathy outcomes in children: how concerned should we be?

Pediatric nephrology (Berlin, Germany)·2025
Same author

Spatial Radiomic Graphs for Outcome Prediction in Radiation Therapy-treated Head and Neck Squamous Cell Carcinoma Using Pretreatment CT.

Radiology. Imaging cancer·2025
Same author

Phosphorylation of CRYAB induces a condensatopathy to worsen post-myocardial infarction left ventricular remodeling.

The Journal of clinical investigation·2025
Same author

Mitophagy Facilitates Cytosolic Proteostasis to Preserve Cardiac Function.

bioRxiv : the preprint server for biology·2024
Same journal

Extracellular matrix reprogramming by the YAP/TAZ- TGF-ß2 axis drives immune exclusion in cholangiocarcinoma models.

The Journal of clinical investigation·2026
Same journal

Tumor cell-derived extracellular vesicles foster the immunosuppressive landscape of pancreatic cancer.

The Journal of clinical investigation·2026
Same journal

Julie Zikherman receives the ASCI/Marian W. Ropes, MD, Award.

The Journal of clinical investigation·2026
Same journal

Targeted degradation of MDM2 overcomes feedback regulation of p53 signaling in Merkel cell carcinoma models.

The Journal of clinical investigation·2026
Same journal

SGLT2 inhibitors enhance ketogenesis by acting as allosteric activators of the mitochondrial enzyme HMGCS2.

The Journal of clinical investigation·2026
Same journal

MDM2 degraders for Merkel cell carcinoma: round peg in a round hole.

The Journal of clinical investigation·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

9.8K

Nipping at cardiac remodeling.

Russell S Whelan1, Kartik Mani, Richard N Kitsis

  • 1Department of Medicine, Cardiovascular Research Center, Albert Einstein College of Medicine, New York, New York, USA.

The Journal of Clinical Investigation
|October 3, 2007
PubMed
Summary
This summary is machine-generated.

Bnip3 protein drives heart enlargement and dysfunction after myocardial infarction in mice. This study reveals Bnip3

More Related Videos

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

4.6K
An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
09:29

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

Published on: July 14, 2023

1.4K

Related Experiment Videos

Last Updated: May 6, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

9.8K
Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents
07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

4.6K
An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
09:29

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice

Published on: July 14, 2023

1.4K

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Cell Death Mechanisms

Background:

  • Myocardial infarction (MI) triggers adverse cardiac remodeling, a major cause of mortality.
  • Cardiomyocyte apoptosis was previously implicated in post-MI cardiac remodeling.
  • The specific molecular mediators of this remodeling process remain incompletely understood.

Discussion:

  • This study investigates the role of Bnip3, a proapoptotic protein, in post-MI cardiac remodeling.
  • The research focuses on how Bnip3 influences cardiac structure and function following ischemic events.
  • The findings differentiate the role of Bnip3 in remodeling versus direct infarct size.

Key Insights:

  • Bnip3 mediates cardiac enlargement, reshaping, and dysfunction in a mouse model of MI.
  • Bnip3's proapoptotic function contributes to adverse cardiac remodeling independently of infarct size.
  • This highlights Bnip3 as a critical molecular player in the maladaptive response to heart attack.

Outlook:

  • Targeting Bnip3 may offer a novel therapeutic strategy to prevent heart failure after MI.
  • Further research is needed to elucidate the precise signaling pathways regulated by Bnip3 in cardiomyocytes.
  • Understanding Bnip3's role can lead to improved treatments for post-MI cardiac dysfunction.